Epigral Ltd advances specialty chemicals with new R&D facility in Gujarat
Epigral Ltd, a leading integrated chemical manufacturer in India, announced the launch of its first research and development centre located in Ahmedabad, Gujarat. This move represents a significant enhancement of the company’s research capabilities and marks a pivotal step in its journey towards developing specialty products.
Advanced R&D Centre in Ahmedabad
Situated in Changodar, Ahmedabad, the new R&D centre spans an area of 14,374 sq. mt. It is equipped with the latest state-of-the-art technologies, positioning Epigral to identify specialty chemical molecules for future introduction in India. This development underscores Epigral’s transition from a chemical manufacturer to a research-driven enterprise, focusing on in-house product development.
Investment and Expansion Plans
The R&D centre has been established with an initial investment of Rs. 30 Crore. Epigral Ltd plans to further invest in enhancing the facility’s capabilities as it progresses, demonstrating a commitment to innovation and growth in the chemical manufacturing sector.
Comments from Epigral Ltd’s Leadership
Maulik Patel, Chairman & Managing Director of Epigral Ltd, commented on the launch, emphasizing the R&D centre’s role in creating molecules with wide-ranging applications in manufacturing pharmaceutical and agrochemical active ingredients. He highlighted the company’s investment in research as a testament to its focus on progress and contribution to India’s self-sufficiency in specialty chemicals.
Introducing New Molecules and Meeting Manufacturing Needs
The company aims to introduce new molecules indigenous to India through this R&D centre, addressing both domestic and global custom manufacturing requirements. The centre will focus on discovering new molecules within the Chlorotoluene ecosystem and establishing advanced specialty intermediates.
Impact on the Indian Chemical Industry
Epigral Ltd’s new R&D centre is set to play a crucial role in the Indian chemical industry, introducing import-substitute molecules and enhancing the country’s Atmanirbhar capabilities. This facility will contribute significantly to the advancement of the chemical manufacturing sector in India.